[{"data":1,"prerenderedAt":109},["ShallowReactive",2],{"drug-tizanidine":3},{"id":4,"schemaVersion":5,"name":6,"category":9,"class":10,"brands":13,"synonyms":17,"formulations":20,"regimens":43,"contraindications":76,"warnings":96,"renal":97,"monitoring":98,"interactions":99,"review":100,"examples":103},"tizanidine",1,{"fa":7,"en":8},"تیزانیدین","Tizanidine","neurology",{"fa":11,"en":12},"شل‌کننده عضلانی (آگونیست α2)","Muscle relaxant (alpha-2 agonist)",[14],{"name":15,"market":16},"Zanaflex","US",[18,19,7],"zanaflex","زانافلکس",[21,35],{"id":22,"form":23,"route":24,"label":25,"concentration":26,"markets":30,"refs":31},"tab-2","tablet","oral","2 mg tablet (scored)",{"amount":27,"unit":28,"perUnit":23,"scored":29},2,"mg",true,[16],[32],{"source":33,"section":34},"fda-tizanidine","3",{"id":36,"form":23,"route":24,"label":37,"concentration":38,"markets":40,"refs":41},"tab-4","4 mg tablet (scored)",{"amount":39,"unit":28,"perUnit":23,"scored":29},4,[16],[42],{"source":33,"section":34},[44],{"id":45,"disease":45,"label":46,"population":49,"type":53,"unit":28,"dose":54,"refs":57,"limits":60,"notes":65},"spasticity",{"fa":47,"en":48},"اسپاستیسیتی — شروع ۲ mg هر ۶ تا ۸ ساعت در صورت نیاز (حداکثر ۳ نوبت)","Spasticity — start 2 mg every 6–8 h as needed (max 3 doses)",{"minAge":50},{"value":51,"unit":52},18,"year","fixed",{"perDose":27,"dosesPerDay":55,"intervalHours":56},3,8,[58],{"source":33,"section":59},"2.2",{"maxPerDay":61,"refs":62},36,[63],{"source":33,"section":64},"2",[66],{"text":67,"refs":70},{"fa":68,"en":69},"افزایش ۲ تا ۴ mg در هر دوز هر ۱ تا ۴ روز؛ حداکثر ۳۶ mg\u002Fday. آنزیم‌های کبدی در ابتدا و یک ماه بعد. قطع تدریجی ۲ تا ۴ mg در روز.","Increase by 2–4 mg per dose every 1–4 days; max 36 mg\u002Fday. Check liver enzymes at baseline and 1 month. Taper by 2–4 mg\u002Fday when stopping.",[71,72,74],{"source":33,"section":64},{"source":33,"section":73},"2.1",{"source":33,"section":75},"2.5",[77,86],{"id":78,"severity":79,"text":80,"refs":83},"ci","block",{"fa":81,"en":82},"همراه مهارکننده‌های قوی CYP1A2 (فلووکسامین، سیپروفلوکساسین)؛ حساسیت.","With strong CYP1A2 inhibitors (fluvoxamine, ciprofloxacin); hypersensitivity.",[84],{"source":33,"section":85},"4",{"id":87,"severity":79,"rule":88,"text":90,"refs":93},"child",{"maxAge":89},{"value":51,"unit":52},{"fa":91,"en":92},"در کودکان ثابت نشده.","Not established in children.",[94],{"source":33,"section":95},"8.4",[],[],[],[],{"status":101,"reviewer":102,"date":102},"unverified",null,[104],{"regimen":45,"formulation":22,"input":105,"expect":108},{"ageYears":106,"weightKg":107},40,70,{"perDose":27},1792078541104]